Cullgen

About:

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

Website: http://www.cullgen.com

Top Investors: HongShan, Highlight Capital, Sincere Capital, Heights Capital Management, Octagon Capital Advisors

Description:

Cullgen is a drug discovery service intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on the selective degradation of disease-causing proteins, a novel treatment for cancer, inflammatory and autoimmune diseases, including targets previously considered undruggable, enabling scientists with new means to develop novel therapeutic approaches for various diseases.

Total Funding Amount:

$106M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-01-01

Contact Email:

inquiries(AT)cullgen.com

Founders:

Jian Jin, Yue Xiong

Number of Employees:

51-100

Last Funding Date:

2023-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai